NCT01900054View on ClinicalTrials.gov

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Bepotastine besilate

Two TAU-284 5mg tablets will be taken orally twice a day

Trial Locations (1)

Unknown

Reserch site, Kanagawa

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY